Pharmacodynamic Analysis of DNA Damage Biomarkers in CTCs as Part of the Phase III BEACON Trial in Breast Cancer
Discover our resources
Resource types
Topics
-
Download Case Study Pharmacodynamic Analysis of DNA Damage Biomarkers in CTCs as Part of the Phase III BEACON Trial in Breast Cancer
-
Download Case Study Therapeutic Target Analysis in CTCs Isolated from NSCLC Patients Using ApoStream®
Therapeutic Target Analysis in CTCs Isolated from NSCLC Patients Using ApoStream®
-
Download Case Study Validation of an LSC Method for Measurement of γH2AX in Human Peripheral Blood Mononuclear Cells
Validation of an LSC Method for Measurement of γH2AX in Human Peripheral Blood Mononuclear Cells
-
Download Case Study A Natural History Study Poses a Distinct Enrollment Challenge
A Natural History Study Poses a Distinct Enrollment Challenge
-
Download Case Study The task was straightforward, though extremely difficult: Get the FDA to consider a different efficacy endpoint for approval.
The task was straightforward, though extremely difficult: Get the FDA to consider a different efficacy endpoint for approval.
-
Download Case Study Characterization of Specific EGFR Mutations in CTCs Isolated by ApoStream® in NSCLC Patients
Characterization of Specific EGFR Mutations in CTCs Isolated by ApoStream® in NSCLC Patients
-
Download Case Study Navigating logistical complexity in cell therapy trials
Navigating logistical complexity in cell therapy trials
-
Download Case Study A Study of the eIF4E Pathway in CTCs Isolated from NSCLC and Prostate Cancer Patients Using ApoStream®
A Study of the eIF4E Pathway in CTCs Isolated from NSCLC and Prostate Cancer Patients Using ApoStream®
